Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.
A DNA copy of the influenza virus hemagglutinin gene, derived from influenza virus A/Jap/305/57 (H2N2) was inserted into the genome of vaccinia virus under the control of an early vaccinia virus promoter. Tissue culture cells infected with the purified recombinant virus synthesized influenza hemagglutinin, which was glycosylated and transported to the cell surface where it could be cleaved with trypsin into HA1 and HA2 subunits. Rabbits and hamsters inoculated intradermally with recombinant virus produced circulating antibodies that inhibited hemagglutination by influenza virus. Furthermore, vaccinated hamsters achieved levels of antibody similar to those obtained upon primary infection with influenza virus and were protected against respiratory infection with the A/Jap/305/57 influenza virus.
D000818:Animals; D000917:Antibody Formation; D006224:Cricetinae; D004274:DNA, Recombinant / Q000378:metabolism*; D004279:DNA, Viral / Q000235:genetics*; D005814:Genes, Viral; D006367:HeLa Cells; D006389:Hemagglutinins, Viral / Q000235:genetics*; D006801:Humans; D007113:Immunity, Innate; D009980:Influenza A virus / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D007251:Influenza, Human / Q000276:immunology; D008647:Mesocricetus; D014162:Transfection; D014616:Vaccinia virus / Q000235:genetics* / Q000276:immunology; D010948:Viral Plaque Assay
D004274:DNA, Recombinant; D004279:DNA, Viral; D006389:Hemagglutinins, Viral